X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.fiercepharma.com/pharma/boehringer-ingelheim-slashes-out-pocket-inhaler-prices-35
https://www.prnewswire.com/news-releases/lupin-launches-tiotropium-dry-powder-for-inhaler-for-the-treatment-of-copd-in-the-united-states-301902771.html
https://www.prnewswire.com/news-releases/lupin-announces-health-canada-approval-of-tiotropium-bromide-inhalation-powder-for-treatment-of-copd-301874184.html
https://endpts.com/lupin-wins-first-fda-approval-for-generic-of-boehringer-blockbuster-spiriva/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211287
https://www.lupin.com/lupin-announces-health-canada-approval-of-tiotropium-bromide-inhalation-powder-for-treatment-of-copd/#:~:text=Quebec%2C%20Mumbai%2C%20May%2026%2C,of%20chronic%20obstructive%20pulmonary%20disease
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-tiotropium-bromide-47342.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupins-uk-subsidiary-gets-mhra-approval-for-copd-treatment/articleshow/93798395.cms
https://www.prnewswire.com/news-releases/new-study-further-supports-the-benefits-of-spiriva-respimat-in-the-treatment-of-asthma-300996550.html
https://www.veronapharma.com/media/verona-pharma-reports-positive-top-line-data-4-week-phase-2b
https://www.fiercepharma.com/pharma/bi-eli-lilly-s-jardiance-nabs-fda-fast-track-for-chronic-heart-failure-studies
https://www.fiercepharma.com/manufacturing/boehringer-ingelheim-opens-inhaler-plant-200-jobs
http://www.pmlive.com/pharma_news/boehringer_eyes_rare_disease_use_for_respiratory_blockbuster_1288847
http://www.pmlive.com/pharma_news/with_spiriva_under_pressure,_boehringer_moves_to_bolster_pipeline_1284948
https://www.fiercepharma.com/marketing/amgen-glaxosmithkline-boehringer-brands-snag-quarterfinal-spots-fiercemadness-dtc
https://www.pharmacompass.com/pdf/news/spiriva-tiotropium-bromide-boehringer-ingelheim-vs-lupin-1543988118.pdf
https://www.lifesciencesipreview.com/contributed-article/boehringer-v-teva-italian-court-clarifies-boundaries-of-bolar-privilege
https://www.prnewswire.com/news-releases/theravance-biopharma-and-mylan-report-positive-new-data-from-multiple-studies-of-yupelri-revefenacin-at-the-2018-chest-annual-meeting-300729073.html
https://www.prnewswire.com/news-releases/fda-approves-stiolto-respimat-supplemental-new-drug-application-snda-to-add-data-on-copd-exacerbation-reduction-300729059.html
https://www.prnewswire.com/news-releases/theravance-biopharma-and-mylan-report-positive-new-data-from-multiple-studies-of-yupelri-revefenacin-at-the-2018-chest-annual-meeting-300729073.html
https://www.prnewswire.com/news-releases/fda-approves-stiolto-respimat-supplemental-new-drug-application-snda-to-add-data-on-copd-exacerbation-reduction-300729059.html
https://www.prnewswire.com/news-releases/theravance-biopharma-and-mylan-report-positive-new-data-from-multiple-studies-of-yupelri-revefenacin-at-the-2018-chest-annual-meeting-300729073.html
https://www.prnewswire.com/news-releases/fda-approves-stiolto-respimat-supplemental-new-drug-application-snda-to-add-data-on-copd-exacerbation-reduction-300729059.html
https://www.news-medical.net/news/20180917/Boehringer-Ingelheim-announces-study-results-of-COPD-patients-treated-with-Spiolto-Respimat.aspx
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-inks-licensing-pact-for-generic-tiotropium-bromide-dry-powder-inhaler-in-western-europe/articleshow/65589186.cms
https://www.pharmacompass.com/pdf/news/spiriva-tiotropium-bromide-boehringer-ingelheim-pharmaceuticals-v-lupin-ltd-1534573576.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-spiriva-21395-tiotropium-bromide-inhalation-powder-capsules-1531283756.pdf
http://www.pharmatimes.com/news/boehingers_spiriva_gets_uk_license_for_young_asthma_patients_1238993
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-7-2018-1517980699.pdf
http://www.fiercepharma.com/marketing/asthma-s-a-real-bear-boehringer-ingelheim-s-new-tv-campaign-for-spiriva-respimat
http://www.prnewswire.com/news-releases/new-analyses-show-spiriva-respimat-tiotropium-bromide-inhalation-spray-improves-breathing-for-people-with-asthma-regardless-of-bmi-or-allergic-status-300462214.html
http://www.livemint.com/Companies/TjmU0WPXIeWYj9IgwjHrPN/Glenmark-gets-USFDA-nod-to-start-phaseII-clinical-trials-fo.html
http://www.prnewswire.com/news-releases/fda-expands-approval-of-spiriva-respimat-tiotropium-bromide-inhalation-spray-for-maintenance-treatment-of-asthma-in-children-300408750.html
http://www.fiercepharma.com/pharma/medicare-medcaid-pony-up-for-big-price-hikes-2015-data-show
http://www.prnewswire.com/news-releases/new-data-stiolto-respimat-tiotropium-bromideolodaterol-inhalation-spray-significantly-improved-exercise-capacity-in-people-with-copd-300322469.html
http://www.pmlive.com/pharma_news/boehringer_starts_to_feel_impact_of_spiriva_generics_1089600
http://www.prnewswire.com/news-releases/new-analyses-adding-spiriva-respimat-effective-for-uncontrolled-asthma--regardless-of-allergy-subtype-300231756.html
http://www.prnewswire.com/news-releases/spiriva-respimat-now-available-in-the-us-for-maintenance-treatment-of-asthma-in-adults-and-adolescents-300214457.html
http://www.prnewswire.com/news-releases/copd-therapeutics-market-hit-92-billion-in-2014-and-will-add-2-billion-by-2021-says-gbi-research-560403411.html
http://www.fiercepharmamarketing.com/story/obstacles-aside-boehringer-sees-class-topping-prospects-ofev-spiolto/2015-10-01
http://www.prnewswire.com/news-releases/despite-generic-erosion-of-current-market-leaders-the-asthma-market-will-remain-steady-over-the-next-decade-largely-owing-to-the-forecasted-launch-of-a-new-class-of-therapy-300147049.html
http://pharmatimes.com/Article/15-08-10/Three_new_drugs_green-lighted_for_NHS_Scotland.aspx
http://www.pharmatimes.com/Article/15-07-02/Boehringer_COPD_combination_approved_in_Europe.aspx
http://www.fiercepharma.com/story/boehringer-gets-respiratory-boost-batch-spiolto-nods-eu/2015-07-02
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206756Orig1s000ltr.pdf
Market Place
Share 
